BEN
45
3
ROK
55
8
FOXA
55
9
HIG
67
4
APA
21
2
EXR
57
-2
TAP
58
-2
COF
55
-3
ADP
64
2
K
53
2
TGT
25
-24
IP
70
2
IFF
53
2
SRE
63
-3
V
60
-6
LB
34
8
DOV
61
-2
BAC
50
-3
NWS
62
-2
CAH
47
3
BEN
45
3
ROK
55
8
FOXA
55
9
HIG
67
4
APA
21
2
EXR
57
-2
TAP
58
-2
COF
55
-3
ADP
64
2
K
53
2
TGT
25
-24
IP
70
2
IFF
53
2
SRE
63
-3
V
60
-6
LB
34
8
DOV
61
-2
BAC
50
-3
NWS
62
-2
CAH
47
3
Financhill
Back

Bicycle Therapeutics PLC Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17

BCYC
Bicycle Therapeutics PLC

Last Price:
20.29
Seasonality Move:
24.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Bicycle Therapeutics PLC Price Quote

$20.29
+0.03 (+-0.34%)
(Updated: November 22, 2024 at 2:28 AM ET)

Bicycle Therapeutics PLC Key Stats

Sell
17
Bicycle Therapeutics PLC (BCYC) is a Sell
Day range:
$19.85 - $20.71
52-week range:
$13.07 - $28.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
28.56
P/B ratio:
1.7%
Volume:
758.4K
Avg. volume:
470.2K
1-year change:
50.52%
Market cap:
$1.4B
Revenue:
$27M
EPS:
$-3.29

How Much Does Bicycle Therapeutics PLC Make?

Is Bicycle Therapeutics PLC Growing As A Company?

Bicycle Therapeutics PLC Stock Price Performance

What Is Bicycle Therapeutics PLC 52-Week High & Low?

Bicycle Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bicycle Therapeutics PLC?

Is Bicycle Therapeutics PLC Cash Flow Positive?

  • What Is BCYC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$202.6M
  • What Is Bicycle Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $519.9M
  • What Is Bicycle Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$918K

Bicycle Therapeutics PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    BCYC return on invested capital is -27.99%
  • What Is Bicycle Therapeutics PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -21.68%
  • What Is BCYC Return On Equity?
    ROE is a measure of profitability and is -29.19%

Bicycle Therapeutics PLC Earnings Date & Stock Price

Bicycle Therapeutics PLC Competitors

Bicycle Therapeutics PLC Dividend Yield

Bicycle Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.46%
Revenue: -50% -61.8%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 37.82
Upside from Last Price: 86.66%

Major Shareholders

  • How many BCYC shares are owned by institutional investors?
    54.7M BCYC shares are owned by institutional investors
  • How many BCYC shares are owned by insiders?
    1.1M BCYC shares are owned by insiders